Clinical trial · Interventional
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
Digital Patient Support Program for Self-Efficacy and Medication Adherence Amongst Women on Adjuvant Endocrine Treatment for Breast Cancer: A Randomized Controlled Trial
NCT06989450CI-TRIAL-00090139recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sidekick digital patient support program for patients with breast cancer | Device | — | UNRESOLVED |
| Standard of care for breast cancer patients | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Digital intervention group
- description
- Participants will be instructed to download Sidekick Health app and receive a code to access the digital intervention in addition to standard of care, as is defined for the control arm. The digital patient support program empowers self-efficacy as well as positive lifestyle change by gamification, altruistic rewards, and engaging content with relevant tasks or missions to be completed. The Sidekick platform includes a medication center, which constitutes of behavioral change educational material and methods aimed at improving adherence. Beyond this, all participants in the interventional arm will also receive standard of care as defined for the control arm.
- interventionNames
- Device: Sidekick digital patient support program for patients with breast cancer
- Other: Standard of care for breast cancer patients
- type
- ACTIVE_COMPARATOR
- label
- Standard of care - control group
- description
- The participants in the control arm will receive standard-of-care treatment. Standard of care includes adjuvant breast cancer treatment and any optional cancer rehabilitation that is not delivered through a mobile application.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (18 years or older) diagnosed with breast cancer of stage I, II or III from 1st September 2023 or later * Have been prescribed adjuvant endocrine therapy for breast cancer. * Understands written and spoken Icelandic or English. * Owns a smart-phone compatible with the Sidekick app and capable to use it * Willing to download the Sidekick app on the smart-phone and to comply with the study measures and visits according to the protocol. * Capable of providing informed consent for participating in the study. Exclusion Criteria: * Having other concurrent conditions that in the opinion of the oncologist may compromise patient safety or study objectives. * Concurrent participation in another clinical study in which the study treatment may confound the evaluation of the investigational program. * Metastatic breast cancer (stage IV) * Previous experience with Sidekick breast cancer program
References
Publications (0)
Data not yet available
No reference posted for this study.